Mysore Medical College and Research Institute, Mysore.
J Assoc Physicians India. 2022 Apr;70(4):11-12.
Magnesium is the fourth most common cation in the body. This ion is now established as a central electrolyte in a large number of cellular metabolic reactions. Low magnesium status has repeatedly been demonstrated in patients with type 2 diabetes. Hypo-magnesemia has been definitely shown to be associated with increased risk of Diabetes mellitus, but its association with retinopathy has been inconclusive and hence this current study has been undertaken to evaluate the association of serum levels of magnesium with retinopathy in type 2 diabetes and correlation with long term control of diabetes mellitus.
There are 150 eligible patients selected from the opd of tertiary care center mysore, karnaaka from jan 2020 to dec 2020. It is a Hospital based Cross sectional study, and statistical software namely Epi-info and open epi software were used for the analysis of the data obtained.
The present study included 150 type 2 diabetic patients. out of 150 diabetic patients 99 were male and 51 were female with male to female ratio was 2:1. We found that the maximum number of patients were from the 55-60 years group. The minimum age in the case group was 37 years and the maximum age was 76 years, with the mean being 55 + 8 years. maximum patients had (29.34 %) PDR, whereas least common (5.33%) had very severe NPDR, moderate NPSeen in 26 % of patients, on the other hand No And Severe NPSeen in around 16 % and 17.33 % respectively. Relationship between grade of retinopathy and serum magnesium level shows that mean of PDR was 1.6 with less standard deviation with narrow confidence interval which make it more reliable value. Relationship between prevalance of diabetic retinopathies and serum Mg level shows that around 70 % diabetics have mg level in between 1.8 to 2.5 mg/dl, maximum patients have moderate NPDR (31) out of 110 patients. It showed that serum magnesium level has statistically significant association with type of diabetic retinopathies.
In patients with retinopathy Serum Mg level was significantly low as compared to those without retinopathy. The mean serum Mg was significantly low in patients PAs compared to those with NP.
镁是体内第四大常见阳离子。这种离子现在被确定为许多细胞代谢反应中的中心电解质。大量研究表明 2 型糖尿病患者存在低镁血症。低镁血症与糖尿病风险增加肯定相关,但与视网膜病变的关系尚无定论,因此本研究旨在评估 2 型糖尿病患者血清镁水平与视网膜病变的关系及其与糖尿病长期控制的相关性。
本研究为 2020 年 1 月至 2020 年 12 月期间在卡纳塔克邦迈索尔的三级护理中心的门诊患者中选择了 150 名符合条件的患者。这是一项基于医院的横断面研究,使用 Epi-info 和开放式 epi 软件等统计软件对获得的数据进行分析。
本研究包括 150 名 2 型糖尿病患者。在 150 名糖尿病患者中,99 名男性,51 名女性,男女比例为 2:1。我们发现,年龄最大的患者来自 55-60 岁组。病例组的最小年龄为 37 岁,最大年龄为 76 岁,平均年龄为 55+8 岁。最多的患者有(29.34%)PDR,而最少的(5.33%)有非常严重的 NPDR,26%的患者有中度 NPDR,另一方面,无和严重 NPDR 分别占 16%和 17.33%。视网膜病变程度与血清镁水平的关系表明,PDR 的平均值为 1.6,标准差较小,置信区间较窄,这使其成为更可靠的值。糖尿病性视网膜病变与血清 Mg 水平的相关性研究表明,约 70%的糖尿病患者的 Mg 水平在 1.8-2.5mg/dl 之间,110 名患者中最多的是中度 NPDR(31 名)。结果表明,血清镁水平与糖尿病性视网膜病变的类型有统计学上的显著关联。
与无视网膜病变的患者相比,有视网膜病变的患者血清镁水平显著降低。与 NP 患者相比,PAs 患者的平均血清 Mg 明显较低。